FTSE 100 news / Companies and sectors / Pharma and healthcare / 10 October 2026
Pharma and healthcare: sector news on Saturday 10 October 2026
Average tone +2.2 (slightly positive) across 5 companies with relevant coverage, from 32 stories.
Company by company
| Company | Tone | Stories | What the coverage was about |
|---|---|---|---|
| GSK | +6.8 | 19 | Coverage was dominated by GSK's plan to invest more than $800 million in Pennsylvania, creating over 300 jobs. |
| AstraZeneca | +2.0 | 9 | Coverage centred on the Summit Therapeutics investment and a CE mark for a companion diagnostic tied to AstraZeneca's breast cancer drug. |
| Haleon | −1.2 | 2 | Coverage was mixed: a new gum health study was presented as long-term upside in oral care, while JPMorgan's negative catalyst watch drew scrutiny to the shares. |
| Convatec | +3.0 | 1 | Coverage was a single piece noting that Convatec shares edged higher in a quiet advance. |
| Smith & Nephew | +0.5 | 1 | Coverage was limited to a note that the shares were trading without their dividend. |
Strongest stories in the sector
- −7.7 Why Is Haleon plc (HLN) Drawing Scrutiny After JPMorgan Flagged A Negative Catalyst Watch?
JPMorgan negative catalyst watch draws scrutiny to the shares. - +7.5 Guardant Health Assay Nabs CE Mark as CDx for AstraZeneca’s Etcamah in Breast Cancer
CE mark for diagnostic paired with AstraZeneca's breast cancer drug. - +7.5 Guardant360 CDx Gains CE Mark as Camizestrant Companion Diagnostic
Companion diagnostic CE mark supports camizestrant, AstraZeneca's drug. - +7.5 GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen
$800M R&D and manufacturing hub commitment. - +7.5 GSK to expand its Montco operations, add more than 300 jobs
Expansion adding over 300 jobs shows growth commitment in US. - +7.3 Pennsylvania says GSK to invest more than $800 million in biopharma hub, create 300 jobs
Reuters reports $800M Pennsylvania hub investment. - +7.2 GSK investing $800 million to expand in Montgomery County
$800M Montgomery County expansion is positive investment news. - +7.0 GSK sinks another $800M into its Pennsylvania operations
Further $800M US investment signals confidence and capacity growth. - +7.0 GSK commits $800M to build new Upper Merion facility as pharma investment surges
New Upper Merion facility funded with $800M. - +7.0 GSK to expand Pennsylvania presence with over $800M investment
Over $800M expansion of Pennsylvania presence. - +7.0 GSK to invest more than $800 million in Pennsylvania biopharma hub
Over $800M biopharma hub investment. - +7.0 Haleon’s New Gum Health Study Signals Long-Term Upside In Oral Care
New gum health study framed as long-term upside for oral care.
Pharma and healthcare: every day · FTSE 100 overview for the day